Providence cancer research gets boost from Fred Meyer shoppers and employees

April 02, 2013

Portland, Ore. — It is true: every little bit counts.

Thousands of Fred Meyer customers and employees joined together to donate $96,000 to research at Providence Cancer Center. Representatives of Fred Meyer recently presented the contribution to Providence. The sum is the result of the store chain’s third quarter employee giving campaign and all the pennies, nickels, dimes and quarters dropped in the coin boxes in the checkout lines in the Portland area locations.

“When given a choice of where to direct our coin box and employee giving funds in the area of cancer research, our Portland area store employees recognized what incredible work Providence does in our community and made it clear that it was an organization they really wanted to support,” said Zach Stratton, Fred Meyer spokesperson.

“The journey to finding a cure for cancer is a long one, and requires many partners,” said Walter J. Urba, M.D., Ph.D., director, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute, Providence Cancer Center. “We consider Fred Meyer and its wonderful employees and customers our partners on this journey. Their financial support enables our researchers to do what they do best – explore the mysteries of cancer, and develop treatments that will save lives.”
 
The $96,000 donation will help support the work of the research teams at Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center.

Providence researchers have focused on immunotherapy since the center opened 20 years ago. People often think of cancer treatment as chemotherapy, surgery and radiation. Immunotherapy is considered the fourth modality. Immunotherapy takes advantage of a patient’s own immune system to fight the disease, while minimizing damage to healthy tissue.

A team of nearly 100 people work in the cancer research center, ranging from the scientists at the bench to staff managing clinical trials.